课题基金 / 基金详情

Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx

Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx
影响肺炎链球菌从鼻咽部侵入后中耳早期清除的宿主因素
批准号:
10358434
负责人:
Sarah E Clark
金额:
$19.44万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-02-01 至 2025-01-31

项目摘要

项目成果

Sarah E Clark的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary This proposal addresses the clinically significant issue of bacterial otitis media (OM), a major source of hospital visits and preventable hearing loss in young children and the most common diagnosis for antibiotic prescriptions in this age group. Streptococcus pneumoniae is one of the two most common causes of bacterial OM, which results from bacterial invasion from the nasopharynx to the middle ear. Despite widespread vaccine use, S. pneumoniae remains a significant OM pathogen, indicating the need for new therapeutic approaches. However, large knowledge gaps remain regarding the host factors which contribute to bacterial OM pathogenesis. To address these knowledge gaps, we developed a new mouse model of S. pneumoniae invasion to the middle ear. This model is based on the clinical observation that viral co-infection increases OM risk in children, and in mice promotes S. pneumoniae invasion. We find that serial administration of the viral dsRNA analog poly(I:C) is sufficient to promote S. pneumoniae invasion to the middle ear. Poly(I:C) induces the production of type I interferons (IFNs), which contribute to S. pneumoniae survival in other tissues. In the first Aim, we address the hypothesis that type I IFNs enhance S. pneumoniae survival in the middle ear. Type I IFNs can induce production of the anti-inflammatory cytokine IL-10, which we recently demonstrated suppresses protection against S. pneumoniae infection in the lung. Here, we investigate whether IL-10 signaling in poly(I:C) treated mice enhances S. pneumoniae survival following middle ear invasion, as well as the impact of IL-10 on middle ear inflammation. Together, these experiments will determine whether type I IFNs contribute to S. pneumoniae OM pathogenesis. In the second Aim, we investigate the importance of the host microbiome. Children treated with antibiotics are susceptible to recurrent bacterial OM, and pathogens including S. pneumoniae are more resistant to antibiotics than many commensal (non-pathogenic) species. In preliminary data, we find that antibiotic treated mice have increased S. pneumoniae invasion and reduced neutrophil recruitment to the middle ear. We investigate the importance of microbiome-dependent neutrophil recruitment for early clearance of S. pneumoniae following middle ear invasion. In the upper airway, the prevalent commensal Corynebacterium has been identified by next-generation sequencing as negatively correlated with OM in children, indicating a potentially protective role. Here, we determine whether Corynebacterium improves protection against S. pneumoniae OM in our mouse model as a first step toward developing new probiotic-based approaches for OM in children. The long-term goal of these studies is to develop novel immunotherapy and/or probiotic strategies to improve the burden of OM disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Airway Prevotella enhance innate immune-mediated protection against lung infection
  • 批准号:
    10561450
  • 项目类别:
  • 资助金额:
    $49.17万
  • 财政年份:
    2023
  • 负责人:
    Sarah E Clark
  • 依托单位:
Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx
  • 批准号:
    10551220
  • 项目类别:
  • 资助金额:
    $19.44万
  • 财政年份:
    2022
  • 负责人:
    Sarah E Clark
  • 依托单位:
Bacterial-driven immune suppression in the lung
  • 批准号:
    10475452
  • 项目类别:
  • 资助金额:
    $4.04万
  • 财政年份:
    2019
  • 负责人:
    Sarah E Clark
  • 依托单位:
Natural killer cell-derived IL-10 and immunity to Listeria
  • 批准号:
    8975083
  • 项目类别:
  • 资助金额:
    $5.42万
  • 财政年份:
    2014
  • 负责人:
    Sarah E Clark
  • 依托单位:
海外基金